help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Molecular Endocrinology, doi:10.1210/me.2006-0110
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
21/1/274    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wettschureck, N.
Right arrow Articles by Spiegel, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wettschureck, N.
Right arrow Articles by Spiegel, A. M.
Molecular Endocrinology 21 (1): 274-280
Copyright © 2007 by The Endocrine Society

Parathyroid-Specific Double Knockout of Gq and G11 {alpha}-Subunits Leads to a Phenotype Resembling Germline Knockout of the Extracellular Ca2+-Sensing Receptor

Nina Wettschureck, EunAh Lee, Steven K. Libutti, Stefan Offermanns, Pamela G. Robey and Allen M. Spiegel

Pharmakologisches Institut (N.W., S.O.), Universität Heidelberg, 69120 Heidelberg, Germany; and Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research (E.L., P.G.R.), Surgery Branch, Center for Cancer Research, National Cancer Institute (S.K.L.), and Molecular Pathophysiology Section, National Institute on Deafness and Other Communication Disorders (A.M.S.), National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Dr. Nina Wettschureck, Pharmakologisches Institut der Universität Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany. E-mail: nina.wettschureck{at}pharma.uni-heidelberg.de.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
Germline knockout of the extracellular Ca2+-sensing receptor (CaR) leads to a phenotype that includes severe hypercalcemia, hyperparathyroidism, relative hypocalciuria, skeletal abnormalities, retarded growth, and early postnatal death. To investigate the role of heterotrimeric G proteins in CaR signaling, we used cre/lox technology to delete the respective {alpha}-subunits of Gq and G11 selectively in parathyroid cells. Mice that were PTH-Cre+/–; Gnaqflox/flox; Gna11–/– (PTH-G{alpha}q/G{alpha}11-double knockouts) were viable, but showed all the features of germline knockout of the CaR except hypocalcuria. Our results demonstrate the critical role of both Gq and G11 in mediating inhibition of PTH secretion by extracellular Ca2+.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
EXTRACELLULAR CALCIUM HOMEOSTASIS is regulated by a negative-feedback mechanism in which Ca2+ directly inhibits parathyroid gland secretion of PTH. PTH, secreted in response to a fall in Ca2+, acts on bone and kidney, and indirectly on the gut, to raise serum Ca2+, thus closing the feedback loop. The extracellular Ca2+-sensing receptor (CaR) is critical for Ca2+ inhibition of PTH secretion (1). In humans, inactivating mutations in the gene coding for the CaR result in increased serum Ca2+ and PTH that may be mild, as in familial hypocalciuric hypercalcemia, or severe, as in neonatal severe primary hyperparathyroidism (NSPHT) if both alleles are affected (2). Germline knockout of the mouse CaR gene leads to a phenotype mimicking familial hypocalciuric hypercalcemia when one allele is deleted, or to NSPHT, with severe hypercalcemia, skeletal demineralization, and early postnatal lethality, when both alleles are deleted (3).

The CaR is a member of family 3 of the G protein-coupled receptor superfamily (4). This suggests that heterotrimeric G proteins might be critical for Ca2+ inhibition of PTH secretion, but to date there is no clear evidence supporting this hypothesis. Furthermore, the specific G protein(s) to which the CaR couples to mediate inhibition of PTH secretion is unclear (5). There is considerable evidence that the CaR couples to members of the Gq/G11 family (6, 7) but also evidence for coupling to Gi family members (8) as well as G12/G13 (9). There is evidence for expression of members of each of these G protein families in bovine parathyroid glands (10). It is also theoretically possible that the activated CaR inhibits PTH secretion via a G protein-independent mechanism, given recent evidence that not all of the actions of typical seven-transmembrane receptors involve G protein coupling (11).

To test the importance of the Gq/G11 proteins in inhibition of PTH secretion, we employed cre/lox technology to delete the {alpha}-subunits of Gq and G11, G{alpha}q and G{alpha}11, selectively in the parathyroid gland. Previous work in which homozygous germline deletions of either G{alpha}q or G{alpha}11 had been performed did not produce mice with a phenotype resembling that of CaR knockout mice (12), but here we show that parathyroid-selective deletion of both copies of G{alpha}q and G{alpha}11 leads to a phenotype closely resembling that of the CaR knockout, thus demonstrating the critical role of these G proteins in the inhibition of PTH secretion by Ca2+.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
To study the role of Gq/G11 family G proteins in the regulation of PTH secretion, we generated mice that lack the {alpha}-subunits of Gq and G11, G{alpha}q and G{alpha}11, selectively in the parathyroid gland. To do so, we mated mice in which the gene coding for G{alpha}q, Gnaq, is flanked with loxP sites (Gnaqflox; Ref. 13) to the constitutively G{alpha}11-deficient mouse line (Gna11–/–; Ref. 14) and to mice which express the recombinase Cre under control of the human PTH promoter (PTH-Cre+/–; Ref. 15).

To test whether Cre expression indeed leads to parathyroid-specific loss of G{alpha}q protein, we performed Western blots with extracts from parathyroid glands, thyroid, kidney, heart, and other organs from 9-d-old PTH-Cre+/–; Gnaqflox/flox; Gna11–/– mice and wild-type animals (Fig. 1AGo). We found that G{alpha}q/G{alpha}11 protein was almost undetectable in parathyroid glands of PTH-Cre+/–; Gnaqflox/flox; Gna11–/– mice [PTH-G{alpha}q/G{alpha}11-double knockouts (DKOs)], whereas G{alpha}q/G{alpha}11 protein levels were not significantly altered in any other organ tested (Fig. 1AGo).


Figure 1
View larger version (35K):
[in this window]
[in a new window]

  		Fig. 1. Phenotype of parathyroid-specific G{alpha}q/G{alpha}11-deficient (PTH-G{alpha}q/G{alpha}11-DKO) mice. A, Western blots of protein extracts from different organs and glands of wild-type (WT) and PTH-G{alpha}q/G{alpha}11-DKO (DKO) mice with an antibody directed against G{alpha}q/G{alpha}11 ({alpha}-G{alpha}q/G{alpha}11). Reblot with anti-{alpha}-tubulin antibody as loading control. B, Survival rate of control pups (PTH-Cre–/–; Gnaqflox/flox; Gna11wt/wt) and their PTH-G{alpha}q/G{alpha}11-DKO (white) littermates (n = 44 and 56, respectively). C, Example for growth retardation in a PTH-G{alpha}q/G{alpha}11-DKO pup (below) compared with a control littermate (above) (postnatal d 9). D, Statistical evaluation of body weight on postnatal d 9 in control pups (black), pups with one intact G{alpha}q (PTH-Cre+/–; Gnaqflox/wt; Gna11–/–; dark gray) or G{alpha}11 allele (PTH-Cre+/–; Gnaqflox/flox; Gna11+/–; light gray), or PTH-G{alpha}q/G{alpha}11-DKO pups (white) (n = 12, 6, 6, 12 animals per group). *, P < 0.05; ***, P < 0.0005 vs. control.

 
PTH-G{alpha}q/G{alpha}11-DKO pups were born at the expected ratio and were initially indistinguishable from their PTH-Cre–/–; Gnaqflox/flox; Gna11wt/wt littermates. However, during the first days after birth, double-deficient mice failed to thrive and usually died within the first 3 wk after birth, most of them before postnatal d 14 (Fig. 1BGo). Body length and body weight of PTH-G{alpha}q/G{alpha}11-DKO pups was massively reduced at postnatal d 9 (Fig. 1Go, C and D). The body weight of littermates with only one intact allele G{alpha}q or G{alpha}11 was also reduced (Fig. 1DGo), but did not result in impaired survival (data not shown).

Internal organs of PTH-G{alpha}q/G{alpha}11-DKO pups were macroscopically and microscopically normal (data not shown), but reduced in size according to the general growth retardation of these animals. Also, the larynx and its associated structures like thyroid gland were massively retarded in growth (Fig. 2Go, A and B), whereas the size of the parathyroid glands did not differ significantly from that of control mice (Fig. 2Go, A and B). To investigate whether this relative increase of parathyroid gland size was due to enhanced proliferation of mutant cells, we treated 6-d-old wild types and PTH-G{alpha}q/G{alpha}11-DKOs with 5-bromo-2'-deoxyuridine (BrdU). We found that the number of BrdU-positive cells was significantly enhanced in mutant parathyroid cells (Fig. 2Go, C and D).


Figure 2
View larger version (53K):
[in this window]
[in a new window]

  		Fig. 2. Parathyroid hyperplasia in parathyroid-specific G{alpha}q/G{alpha}11-deficient (PTH-G{alpha}q/G{alpha}11-DKO) mice. A, Hematoxylin and eosin staining of coronal sections of tracheal blocks from wild-type (WT) and PTH-G{alpha}q/G{alpha}11-DKO (DKO) pups killed on postnatal d 9. The borders of parathyroid glands are indicated in black (magnification, x50). B, Statistical evaluation of maximal cross-sectional area (in arbitrary units) of parathyroid and thyroid glands in sections of wild-type (black) and PTH-G{alpha}q/G{alpha}11-DKO (white) pups (n = 5 mice per group). C, BrdU staining of sectioned parathyroid glands from 6-d-old wild-type (WT) and PTH-G{alpha}q/G{alpha}11-DKO (DKO) pups killed 4 h after BrdU treatment (magnification, x630). D, Statistical evaluation of BrdU-positive cells per view field in parathyroid glands from wild-type (black) and PTH-G{alpha}q/G{alpha}11-DKO (white) mice (n = 3 mice per group). Ctm, Cricothyroid muscle; tc, thyroid cartilage; cc, cricoid cartilage; t1–3, tracheal rings 1–3; thy, thyroid gland, pth, parathyroid gland. *, P < 0.05; ***, P < 0.001.

 
To test whether parathyroid hyperplasia was associated with increased PTH production, we determined serum PTH levels in wild-type and mutant pups at postnatal d 9 (Fig. 3AGo). Double-deficient pups showed strongly increased PTH levels, and also mice with only one intact G{alpha}q or G{alpha}11 allele in the parathyroid gland had elevated PTH concentrations. Serum calcium levels were strongly increased in PTH-G{alpha}q/G{alpha}11-DKOs, as well as, although less prominent, in animals with one intact G{alpha}q or G{alpha}11 allele (Fig. 3BGo). Urine calcium excretion was also strongly increased in PTH-G{alpha}q/G{alpha}11-DKOs, and animals with one intact G{alpha}q or G{alpha}11 allele showed intermediate values (Fig. 3CGo). To test whether hypercalciuria might be partially due to a down-regulation of PTH receptor subtype 1 (PTH-R1) in response to chronically elevated PTH levels, we performed RT-PCR and Western blotting for the parathyroid receptor subtype 1. We found that expression of PTH-R1 at the mRNA level was not altered in PTH-G{alpha}q/G{alpha}11-DKOs (Fig. 3DGo), and also in Western blotting no marked differences were detected (data not shown)


Figure 3
View larger version (21K):
[in this window]
[in a new window]

  		Fig. 3. Abnormal calcium homeostasis in parathyroid-specific G{alpha}q/G{alpha}11-deficient (PTH-G{alpha}q/G{alpha}11-DKO) mice. A–C, Levels of serum PTH (A), serum calcium (B), and urine calcium (C) on postnatal d 9 in control pups (black), pups with one intact G{alpha}q (PTH-Cre+/–; Gnaqflox/wt; Gna11–/–; dark gray) or G{alpha}11 allele (PTH-Cre+/–; Gnaqflox/flox; Gna11+/–; light gray), or in PTH-G{alpha}q/G{alpha}11-DKO pups (white) (n = 12, 6, 6, 12 pups, respectively). D, Left, Representative examples of RT-PCRs for PTH-R1 and GAPDH as housekeeping gene performed on cDNA from kidneys of wild-type and PTH-G{alpha}q/G{alpha}11-DKO mice. Right, Statistical evaluation of the changes in the PTH-R1/GAPDH ratio between wild-type (black) and PTH-G{alpha}q/G{alpha}11-DKO (white). *, P < 0.05; **, P < 0.005; ***, P < 0.0005; ns, not significant vs. wild type.

 
We next investigated whether loss of G{alpha}q/G{alpha}11 would cause compensatory changes in the expression of the parathyroid calcium-sensing receptor. Western blotting of parathyroid glands as well as immunofluorescence staining of laryngeal sections revealed decreased expression of the parathyroid gland calcium-sensing receptor (Fig. 4Go, A and B).


Figure 4
View larger version (30K):
[in this window]
[in a new window]

  		Fig. 4. Reduced expression of CaR in G{alpha}q/G{alpha}11-deficient (DKO) parathyroid glands. A, Western blot of extracts from parathyroid glands with antibodies directed against G{alpha}q/G{alpha}11, CaR, and {alpha}-tubulin as loading control. B, Immunofluorescence staining with antibody directed against CaR on paraffin sections of tracheal blocks (magnification, x200). Bright red spots are erythrocytes. WT, Wild type; DKO, PTH-G{alpha}q/G{alpha}11-DKO; Th, thyroid; Pth, parathyroid gland.

 
At d 9, PTH-G{alpha}q/G{alpha}11-DKO mice exhibited severe dwarfing, and an axial and appendicular skeletal phenotype compared with wild-type mice. Radiographically, the DKO mice were severely osteopenic throughout the skeleton, with barely detectable mineralization in the bones of the paws and caudal vertebrae (Fig. 5AGo). By staining with alcian blue/alizarin red, a delay in endochondral bone formation was noted in the cervical and caudal vertebrae, bones of the paws, and all long bones (Figs. 5BGo and 6Go, F and J). Mineralization of the ventral ribs was lacking, as well as epiphyseal ossification of the femur and tibia (Fig. 6Go, D and H). All growth plates displayed rachitic changes, as highlighted by the presence of bulging of the costochondral junction (rachitic rosary) in the ribs (Fig. 6DGo). In addition to the profound defects in the axial and appendicular skeleton, abnormalities were also noted in the craniofacial complex, which develop by three different mechanisms: intramembranous bone formation, endochondral bone formation, and a third mechanism that requires remodeling of unmineralized cartilage before bone formation (16). PTH-G{alpha}q/G{alpha}11-DKO mice exhibited a delay in all three of these processes, resulting in an anterior-posterior shortening, most pronounced in the snout, and doming of the cranial vault (Fig. 6BGo). The delay in intramembranous bone formation in the cranial vault resulted in formation of extremely wide sutures, coupled with evidence of bone resorption.


Figure 5
View larger version (54K):
[in this window]
[in a new window]

  		Fig. 5. Severe skeletal phenotype in G{alpha}q/G{alpha}11-deficient (DKO) mice. A, By x-ray analysis, the 9-d-old DKO mice exhibit dramatic dwarfism and osteopenia, with evidence of rachitic changes in growth plates of the long bones compared with WT mice (*). B, Examination of the skeleton by alcian blue/alizarin staining demonstrate regions of delayed bone formation in the cranium (as well as delay of removal of primordial cartilages, stained blue), epiphyses, caudal vertebrae, and paws (arrows) in DKO mice compared with WT mice.

 

Figure 6
View larger version (80K):
[in this window]
[in a new window]

  		Fig. 6. Delay in bone formation and evidence of bone resorption in G{alpha}q/G{alpha}11-deficient (DKO) mice compared with wild type (WT) mice. A and B, Wide sutures, delay of bone formation, and evidence of bone resorption in DKO mice. C and D, Rachitic rosary (*) and delay in bone formation of the ventral ribs in DKO mice. E and F, Delay in bone formation of hindlimb paws in DKO mice. G and H, Secondary ossification sites in the femur of WT mice (*) are absent in DKO mice. I and J, Delay in bone formation of caudal vertebrae in DKO mice.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
MATERIALS AND METHODS
 REFERENCES
 
The key phenotypic features we observed in PTH-G{alpha}q/G{alpha}11-DKO mice, markedly increased serum calcium and PTH, relative increase in parathyroid gland size, severe delay in bone formation and evidence of bone resorption, decreased body size, and early postnatal lethality, all closely resemble the phenotype seen in CaR-null mice. An important phenotypic difference is the increased urinary calcium excretion we observed in PTH-G{alpha}q/G{alpha}11-DKO mice, which contrasts with the relative reduction in urinary calcium excretion seen in CaR-null mice (3). This difference results from the loss in CaR germline null mice of the normal function of the CaR in kidney to promote urinary calcium excretion as serum calcium is elevated, whereas the kidney CaR is intact in PTH-G{alpha}q/G{alpha}11-DKO mice. Increased urinary calcium excretion in the latter is clearly insufficient in preventing severe hypercalcemia. Our results clearly indicate that loss of CaR function exclusively in the parathyroid is sufficient to cause the NSPHT phenotype.

We found no evidence for a compensatory increase in expression of CaR in parathyroids (17) of PTH-G{alpha}q/G{alpha}11-DKO mice, but rather a relative reduction in expression. This may occur as a function of the apparent increase in parathyroid growth, because reduced CaR expression has been noted in other conditions characterized by increased parathyroid cell proliferation (17). A prominent change in CaR expression might affect calcium homeostasis by itself; however, given the small magnitude of CaSR down-regulation, a major contribution to the observed phenotype seems unlikely.

Characterization of the skeletal phenotype in the initial report of germline CaR knockout (KO) mice was limited to a skeletal radiograph showing decreased radiodensity, kyphoscoliosis, and bowing of long bones (3). Subsequently, Garner et al. (18) performed more detailed skeletal analysis and reported that rickets was the predominant skeletal abnormality in germline CaR KO mice. They speculated that aspects of the skeletal phenotype might reflect CaR deficiency in bone cells rather than simply the skeletal consequences of severe hyperparathyroidism. Although we did not perform histologic analyses, our radiographic and skeletal staining results are generally consistent with those of Garner et al., showing not only severe osteopenia but also rachitic changes. Garner et al., however, noted normal craniofacial development in germline CaR KO mice, whereas PTH-G{alpha}q/G{alpha}11-DKO mice show a domed cranial vault, very wide sutures, and other dysmorphic features. A more detailed histological analysis will be required to define fully the basis for abnormal skeletal development in the present model.

Our results show that both G{alpha}q and G{alpha}11 are necessary for normal regulation of PTH secretion by Ca2+. This requirement presumably reflects the coupling of both G proteins to the parathyroid CaR. Both G{alpha}q and G{alpha}11 are expressed in virtually all cells, and they may be functionally redundant in coupling to a variety of G protein-coupled receptors (12). For the parathyroid CaR, there appears to be no functional consequence of deletion of both copies of either G{alpha}q or G{alpha}11. If three of the four alleles of these G proteins were deleted in the parathyroid, however, biochemical abnormalities, albeit less severe than those in DKO mice, were observed. The physiological role, if any, of other G proteins including G{alpha}i and G{alpha}12/13 in coupling to the CaR in parathyroid cells is unclear, but our results do not exclude a role for such proteins in the actions of the CaR in other cells such as in the kidney.

Hypermorphic alleles of G{alpha}q or G{alpha}11 were identified in mice with increased skin pigmentation (19). These mice also showed a reduction in body size that was accentuated with increased number of G protein mutant alleles. No data concerning serum PTH or calcium were provided in this report, nor was the mechanism for growth impairment defined. The functional implications, if any, of activating mutations of G{alpha}q or G{alpha}11 in the parathyroids remains to be determined.

CaR coupling to G{alpha}q or G{alpha}11 is presumed to lead to activation of phospholipase C-ß, which in turn leads to generation of diacylglycerol and inositol 1,4,5-triphosphate and thereby increased intracellular Ca2+. These intracellular signals have been correlated with inhibition of PTH secretion (1, 5). Our results in PTH-G{alpha}q/G{alpha}11-DKO mice do not prove that these signals are critical for inhibition of PTH secretion, but we speculate that this is likely to be the case. Further studies will be needed to verify this hypothesis, and to clarify why such signals, which generally lead to increased protein and hormone secretion, in the parathyroid have the opposite effect.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
REFERENCES
 
Generation of Parathyroid Cell-Specific G{alpha}q/G{alpha}11-Double-Deficient Mice
Parathyroid cell-specific G{alpha}q/G{alpha}11-double-deficient mice (PTH-G{alpha}q/G{alpha}11-DKO) were generated by crossing the parathyroid-specific Cre-expressing line PTH-Cre (PTH-Cre+/–) (15) to mice carrying floxed G{alpha}q alleles (Gnaqflox/flox) (13) and constitutively G{alpha}11-deficient mice (Gna11–/–) (14). Intercrosses between PTH-Cre+/–; Gnaqflox/wt; Gna11–/wt mice resulted in the generation of parathyroid-specific G{alpha}q/G{alpha}11-double-deficient mice (PTH-Cre+/–; Gnaqflox/flox; Gna11–/–), of mice with one intact G{alpha}q or G{alpha}11 allele in the parathyroid gland (PTH-Cre+/–; Gnaqwt/flox; Gna11–/– and PTH-Cre+/–; Gnaqflox/flox; Gna11–/wt, respectively), and control littermates (PTH-Cre–/–; Gnaqflox/flox; Gna11wt/wt). Genotyping for Gnaq and Gna11 alleles was performed as described previously (13). For genotyping of the PTH-Cre transgene, the primers 5'-TAAGCCCCTTGTCAAGCCAAA-3' and 5'-GCAGCGATCGCTATTTTCCAT-3' were used. Animals were on a mixed genetic background with a predominant contribution of the C57BL6/N strain (fourth-generation backcross). In some experiments, also age-matched nonlittermate C57BL6/N wild types were used as controls. Animal experiments were in accordance with Institutional Animal Care and Use Committee regulations.

Electrolyte and Hormone Levels
Serum samples in 9-d-old pups were prepared from blood obtained from the abdominal vena cava under deep anesthesia with 100 mg/kg pentobarbital, ip. Urine was collected by aspiration from the urinary bladder. In PTH-G{alpha}q/G{alpha}11-DKOs mice that survived to an age of 3 wk, blood was collected from the retroorbital plexus. Serum calcium levels were determined with the calcium-o-cresolphthalein complexone method (20). Blood and urine phosphate levels were determined with the Liqui-UV Phosphorus kit (Stanbio, Boernen, TX). Serum PTH levels were determined using a mouse intact PTH ELISA kit (Immutopics, San Clemente, CA).

Histology
Mice were killed at postnatal d 9, and tracheal blocks and other organs were dissected, dehydrated, embedded in paraffin, and sectioned (5 µm) on a rotating microtome (Microm, Walldorf, Germany). Hematoxylin and eosin staining was performed according to standard procedures. For morphometric analysis, sections were digitalized and thyroid and parathyroid cross-sectional area in the section with maximal parathyroid diameter was determined by computerized pixel counting. For immunofluorescence staining, paraffin sections were incubated with polyclonal rabbit calcium-sensing receptor antibody ADD, raised against a synthetic peptide corresponding to residues 214–235 of the human CaR (1:2000; Ref. 21) at 4 C overnight and tetramethylrhodamine isothiocyanate-labeled goat antirabbit antibody (1:200; Jackson ImmunoResearch, West Grove, PA) for 2 h. For BrdU labeling, 6-d-old mice were injected ip with 10 mg/kg body weight BrdU and killed after 4 h. Paraffin sections of the thyroid gland/parathyroid gland were stained with anti-BrdU antibody (BD Biosciences, San Diego, CA; 1:100) and FITC-labeled goat antirabbit antibody (1:200; Jackson ImmunoResearch) for 2 h.

Western Blotting
The thyroid gland was dissected from tracheal blocks, and parathyroid glands were prepared from the lateral lobes of the thyroid gland under a dissection microscope. Parathyroid glands and other tissues were homogenized in hypotonic buffer [10 mM dithiothreitol, 5 mM EDTA, 20 mM HEPES (pH 7.5)] in the presence of protease inhibitors, and after centrifugation the pellet was extracted for 60 min in 20 µl of hypotonic buffer containing 1% deoxycholate. Five micrograms of protein extract were loaded on a 10% SDS-PAGE gel, electrophoresed, blotted, and sequentially probed with polyclonal rabbit antibodies against G{alpha}q/G{alpha}11 (sc-392; 1:500; Santa Cruz Biotechnology, Santa Cruz, CA), polyclonal rabbit antibodies directed against the calcium-sensing receptor, ADD (21), or mouse monoclonal {alpha}-tubulin antibodies (clone DM1a; 1:1000; Sigma-Aldrich, St. Louis, MO). For parathyroid glands, the complete extract from one gland was loaded per lane. Signals were detected by incubation with horseradish peroxidase-conjugated secondary antibodies (1:2000; Sigma-Aldrich). Chemiluminescence was developed using the ECLplus kit (Amersham Biosciences, Freiburg, Germany).

Analysis of the Skeletal Phenotype
Mice were euthanized at postnatal d 9 and radiographic images were obtained using a Faxitron MX-20 Specimen Radiography System (Faxitron X-Ray Corp., Buffalo Grove, IL) at an energy of 30 kV for 90 sec with X-OMAT TL film and processed by an automated x-ray film developer (Eastman Kodak, Rochester, NY). In some cases, mice were skinned and eviscerated, and fixed and stored in 95% ethanol. Cartilage was stained with alcian blue (0.03% in 80% ethanol/20% acetic acid) for 3 d, washed with 95% ethanol for 6 h. After soaking in 2% potassium hydroxide for 24 h, bone was stained with alizarin red (0.03% in aqueous 1% potassium hydroxide) for 24 h, cleared (1% potassium hydroxide/20% glycerol), and stored in 1:1 glycerol/95% ethanol.

Semiquantitative RT-PCR Analysis of PTH-R1 Expression
Total RNA was extracted from mouse kidneys using Trizol according to the manufacturer’s instructions (Invitrogen, Carslbad, CA), and digested with deoxyribonuclease I (Roche Diagnostics, Mannheim, Germany) for 10 min at 37 C. cDNA was synthesized using SuperScript synthesis according to the manufacturer’s instructions (Promega, Madison, WI). A 200-bp sequence spanning exons 8 and 9 of the PTH-R1 gene was amplified in GoTaq green mater mix containing the forward primer, 5'-ATCTTCGTGAAGGACGCTGT-3' and the reverse primer, 5'-CCCTCCACCAGAATCCAGTA-3' (GenBank accession no. NM_011199, bases 709–728, bases 955–974). The target cDNA was amplified during 25 and 30 cycles at 94 C for 30 sec for denaturation, 55 C for 30 sec for annealing, and 72 C for 15 sec for extension. A final extension was at 72 C for 15 sec. For comparison, a 816-bp sequence of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified using the forward primer 5'-AGCCGCATCTTCTTTTGCGTC-3' and the reverse primer 5'-TCATATTTGGCAGGTTTTTCT-3' (GenBank accession no. M33197, bases 12–32, bases 807–827) by running the reaction for 15 min at 94 C, and then 25 and 35 cycles at 94 C for 45 sec, 58 C for 45 sec, and 72 C for 1 min, and final extension at 72 C for 7 min. The amplification products were separated by 1.5% TBE-agarose gel.

Statistics
Values were expressed as mean ± SEM. Differences between two groups were statistically analyzed using unpaired Student’s t test. Differences between more than two groups were analyzed using ANOVA. Statistical significance was accepted at P < 0.05.


   FOOTNOTES
 
This work was supported, in part, by the National Institute on Deafness and Other Communication Disorders, National Cancer Institute, and National Institute of Dental and Craniofacial Research, Intramural Research Programs, National Institutes of Health, Department of Health and Human Services (A.M.S., S.K.L., E.L., P.G.R.).

Present address for A.M.S.: Office of the Dean, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461.

N.W., E.L., S.K.L., and S.O. have nothing to declare. P.G.R. and A.M.S. have equity interests.

First Published Online September 20, 2006

Abbreviations: BrdU, 5-Bromo-2'-deoxyuridine; CaR, Ca2+-sensing receptor; DKO, double knockout; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KO, knockout; NSPHT, neonatal severe primary hyperparathyroidism; PTH-R1, PTH receptor subtype 1.

Received for publication March 7, 2006. Accepted for publication September 14, 2006.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 

  1. Hofer AM, Brown EM 2003 Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4:530–538[CrossRef][Medline]
  2. Hu J, Spiegel AM 2003 Naturally occurring mutations of the extracellular Ca2+-sensing receptor: implications for its structure and function. Trends Endocrinol Metab 14:282–288[CrossRef][Medline]
  3. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE 1995 A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389–394[CrossRef][Medline]
  4. Bockaert J, Pin JP 1999 Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723–1729[CrossRef][Medline]
  5. Ward DT 2004 Calcium receptor-mediated intracellular signalling. Cell Calcium 35:217–228[CrossRef][Medline]
  6. Brown E, Enyedi P, LeBoff M, Rotberg J, Preston J, Chen C 1987 High extracellular Ca2+ and Mg2+ stimulate accumulation of inositol phosphates in bovine parathyroid cells. FEBS Lett 218:113–118[CrossRef][Medline]
  7. Shoback DM, Membreno LA, McGhee JG 1988 High calcium and other divalent cations increase inositol trisphosphate in bovine parathyroid cells. Endocrinology 123:382–389[Abstract]
  8. Chen CJ, Barnett JV, Congo DA, Brown EM 1989 Divalent cations suppress 3',5'-adenosine monophosphate accumulation by stimulating a pertussis toxin-sensitive guanine nucleotide-binding protein in cultured bovine parathyroid cells. Endocrinology 124:233–239[Abstract]
  9. Huang C, Hujer KM, Wu Z, Miller RT 2004 The Ca2+-sensing receptor couples to G{alpha}12/13 to activate phospholipase D in Madin-Darby canine kidney cells. Am J Physiol 286:C22–C30
  10. Varrault A, Pena MS, Goldsmith PK, Mithal A, Brown EM, Spiegel AM 1995 Expression of G protein {alpha}-subunits in bovine parathyroid. Endocrinology 136:4390–4396[Abstract]
  11. Rajagopal K, Lefkowitz RJ, Rockman HA 2005 When 7 transmembrane receptors are not G protein-coupled receptors. J Clin Invest 115:2971–2974[CrossRef][Medline]
  12. Wettschureck N, Moers A, Offermanns S 2004 Mouse models to study G-protein-mediated signaling. Pharmacol Ther 101:75–89[CrossRef][Medline]
  13. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie TM, Chen J, Chien KR, Offermanns S 2001 Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of G{alpha}q/G{alpha}11 in cardiomyocytes. Nat Med 7:1236–1240[CrossRef][Medline]
  14. Offermanns S, Zhao LP, Gohla A, Sarosi I, Simon MI, Wilkie TM 1998 Embryonic cardiomyocyte hypoplasia and craniofacial defects in G{alpha}q/G{alpha}11-mutant mice. EMBO J 17:4304–4312[CrossRef][Medline]
  15. Libutti SK, Crabtree JS, Lorang D, Burns AL, Mazzanti C, Hewitt SM, O’Connor S, Ward JM, Emmert-Buck MR, Remaley A, Miller M, Turner E, Alexander HR, Arnold A, Marx SJ, Collins FS, Spiegel AM 2003 Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res 63:8022–8028[Abstract/Free Full Text]
  16. Holmbeck K, Bianco P, Chrysovergis K, Yamada S, Birkedal-Hansen H 2003 MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J Cell Biol 163:661–671[Abstract/Free Full Text]
  17. Mallya SM, Gallagher JJ, Wild YK, Kifor O, Costa-Guda J, Saucier K, Brown EM, Arnold A 2005 Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism. Mol Endocrinol 19:2603–2609[Abstract/Free Full Text]
  18. Garner SC, Pi M, Tu Q, Quarles LD 2001 Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology 142:3996–4005[Abstract/Free Full Text]
  19. Van Raamsdonk CD, Fitch KR, Fuchs H, de Angelis MH, Barsh GS 2004 Effects of G-protein mutations on skin color. Nat Genet 36:961–968[CrossRef][Medline]
  20. Moorehead WR, Biggs HG 1974 2-Amino-2-methyl-1-propanol as the alkalizing agent in an improved continuous-flow cresolphthalein complexone procedure for calcium in serum. Clin Chem 20:1458–1460[Abstract]
  21. Goldsmith PK, Fan GF, Ray K, Shiloach J, McPhie P, Rogers KV, Spiegel AM 1999 Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J Biol Chem 274:11303–11309[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
N. Ogata, H. Kawaguchi, U.-i. Chung, S. I. Roth, and G. V. Segre
Continuous Activation of G{alpha}q in Osteoblasts Results in Osteopenia through Impaired Osteoblast Differentiation
J. Biol. Chem., December 7, 2007; 282(49): 35757 - 35764.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
21/1/274    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wettschureck, N.
Right arrow Articles by Spiegel, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wettschureck, N.
Right arrow Articles by Spiegel, A. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals